FDA Proposes Ban on Over-the-Counter Decongestant

Washington, D.C. – The Food and Drug Administration (FDA) has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medications, from the market. The agency’s review found that the ingredient is ineffective as a nasal decongestant.

The FDA’s decision is based on a thorough review of scientific data, including the original 30-year-old determination and more recent research. An advisory committee also concluded that there is insufficient evidence to support the effectiveness of oral phenylephrine as a nasal decongestant.

While the FDA’s proposal may raise concerns about the availability of effective cold remedies, it’s important to note that the agency has emphasized that oral phenylephrine is not a safety concern. The proposed ban is solely based on its lack of efficacy.

Consumers are advised to consult with healthcare professionals for guidance on effective treatments for cold and allergy symptoms. Various safe and effective medications and remedies are available to alleviate congestion.

Source: Review Journal